Sight Sciences, Inc.
SGHT
$3.63
$0.164.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.39M | 19.91M | 19.56M | 17.51M | 19.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.39M | 19.91M | 19.56M | 17.51M | 19.07M |
| Cost of Revenue | 2.60M | 2.71M | 2.98M | 2.41M | 2.51M |
| Gross Profit | 17.79M | 17.20M | 16.59M | 15.09M | 16.56M |
| SG&A Expenses | 19.02M | 19.95M | 23.87M | 24.52M | 24.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.05M | 25.01M | 31.23M | 31.37M | 31.00M |
| Operating Income | -3.67M | -5.11M | -11.67M | -13.86M | -11.93M |
| Income Before Tax | -4.15M | -8.25M | -11.90M | -14.11M | -11.81M |
| Income Tax Expenses | 8.00K | -79.00K | 40.00K | 41.00K | 38.00K |
| Earnings from Continuing Operations | -4.16M | -8.17M | -11.94M | -14.15M | -11.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.16M | -8.17M | -11.94M | -14.15M | -11.85M |
| EBIT | -3.67M | -5.11M | -11.67M | -13.86M | -11.93M |
| EBITDA | -3.56M | -5.00M | -11.54M | -13.71M | -11.75M |
| EPS Basic | -0.08 | -0.16 | -0.23 | -0.28 | -0.23 |
| Normalized Basic EPS | -0.05 | -0.07 | -0.14 | -0.17 | -0.15 |
| EPS Diluted | -0.08 | -0.16 | -0.23 | -0.28 | -0.23 |
| Normalized Diluted EPS | -0.05 | -0.07 | -0.14 | -0.17 | -0.15 |
| Average Basic Shares Outstanding | 53.09M | 52.38M | 51.82M | 51.29M | 50.80M |
| Average Diluted Shares Outstanding | 53.09M | 52.38M | 51.82M | 51.29M | 50.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |